现代肿瘤医学
現代腫瘤醫學
현대종류의학
JOURNAL OF MODERN ONCOLOGY
2015年
1期
12-14
,共3页
侯进%李汾%李新华%梅其炳%弥曼
侯進%李汾%李新華%梅其炳%瀰曼
후진%리분%리신화%매기병%미만
MCF-7细胞%百合多糖%金雀异黄素
MCF-7細胞%百閤多糖%金雀異黃素
MCF-7세포%백합다당%금작이황소
MCF-7%lily polysaccharide%genistein
目的:研究百合多糖( LP-1)联合金雀异黄素对人类乳腺癌细胞增殖的影响。方法:培养MCF-7细胞,加入不同浓度的LP-1和金雀异黄素,应用MTT法检测百合多糖对MCF-7细胞增殖的影响;用流式细胞技术( FCM)检测细胞周期。放射性配体结合法检测化合物与雌激素受体( estrogenic receptor,ER)的亲和力。结果:LP-1对MCF-7细胞增殖和细胞周期没有显著影响,和高浓度金雀异黄素合用可以增强金雀异黄素对MCF-7细胞的抗增殖作用,并将细胞周期阻滞在G2期。LP-1对ERα和 ERβ均无亲和力,金雀异黄素对ERα和ERβ均有亲和力,IC50分别(3.51×10-5)mol/L 和(2.12×10-7)mol/L。结论:百合多糖与金雀异黄素合用可能通过不同途径影响MCF-7细胞增殖和凋亡,发挥协同作用。
目的:研究百閤多糖( LP-1)聯閤金雀異黃素對人類乳腺癌細胞增殖的影響。方法:培養MCF-7細胞,加入不同濃度的LP-1和金雀異黃素,應用MTT法檢測百閤多糖對MCF-7細胞增殖的影響;用流式細胞技術( FCM)檢測細胞週期。放射性配體結閤法檢測化閤物與雌激素受體( estrogenic receptor,ER)的親和力。結果:LP-1對MCF-7細胞增殖和細胞週期沒有顯著影響,和高濃度金雀異黃素閤用可以增彊金雀異黃素對MCF-7細胞的抗增殖作用,併將細胞週期阻滯在G2期。LP-1對ERα和 ERβ均無親和力,金雀異黃素對ERα和ERβ均有親和力,IC50分彆(3.51×10-5)mol/L 和(2.12×10-7)mol/L。結論:百閤多糖與金雀異黃素閤用可能通過不同途徑影響MCF-7細胞增殖和凋亡,髮揮協同作用。
목적:연구백합다당( LP-1)연합금작이황소대인류유선암세포증식적영향。방법:배양MCF-7세포,가입불동농도적LP-1화금작이황소,응용MTT법검측백합다당대MCF-7세포증식적영향;용류식세포기술( FCM)검측세포주기。방사성배체결합법검측화합물여자격소수체( estrogenic receptor,ER)적친화력。결과:LP-1대MCF-7세포증식화세포주기몰유현저영향,화고농도금작이황소합용가이증강금작이황소대MCF-7세포적항증식작용,병장세포주기조체재G2기。LP-1대ERα화 ERβ균무친화력,금작이황소대ERα화ERβ균유친화력,IC50분별(3.51×10-5)mol/L 화(2.12×10-7)mol/L。결론:백합다당여금작이황소합용가능통과불동도경영향MCF-7세포증식화조망,발휘협동작용。
Objective:To investigate the effects of lily polysaccharide(LP-1)combined genistein on the prolifera-tion of mammary cancer cells in vitro. Methods:Effects of LP-1 and genistein on the cell proliferation were tested in MCF-7 cell by MTT measurement. Cell cycle was examined by flow cytometry. Competitive estrogen-receptor bind-ing assay was used to investigate the affinity of xy2004 to ER. Results:LP-1 used alone can′t inhibit proliferation of MCF-7 cell,while proliferation of MCF-7 cell was inhibited when LP-1 and genistein used together. The cell cy-cle was arrested to G2 by using polysaccharide and genistein together. The relative binding affinity of genistein for ERαand ERβ showed an IC50 of(3. 51 × 10-5 )mol/L and(2. 12 × 10-7 )mol/L respectively. Conclusion:LP-1 and genistein have the synergistic antitumor action through the different response pathway.